• Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Aim: Purpose of study is to evaluate the end to end commissioning accuracy of intensity modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) for Versa HD linear accelerator using AAPM TG-119 protocol. Materials & methods: IMRT and VMAT plans were created for TG119 test cases. All the plans were generated using Monaco 5.1 treatment planning system (TPS) for Elekta Versa HD linear accelerator. Prescription and planning goals were as kept as per TG119. For point dose measurement CC01 (0.01cc) ion chamber was used and measurements were carried out as per TG119 specified points in high and low dose gradient regions. Planar dose measurement I'matriXX along with multicube-lite phantom was used. Planned and measured dose planes were compared using gamma index criteria. Results: All planning goals have been achieved as per TG119 report. At high dose point measurement mean dose differences averaged over different techniques planned with different energies for all test cases was 0.002?0.020, and corresponding confidence limit was 0.041. At low dose point measurement mean dose averaged over different techniques planned with different energies for all test cases was -0.004?0.021, and corresponding confidence limit was 0.045. For planar dose measurement gamma passing rate averaged over all test cases was 99.40%?0.40 for 3%/3mm criteria and 97.82%?0.13 for 2%/2mm criteria respectively. Present work overall confidence limit for composite planar dose measurement was 1.38(i.e., 98.62% passing) for 3%/3mm and 2.45(i.e., 97.55% passing) for 2%/2mm criteria. Conclusion: Planning and delivery of IMRT/VMAT has been validated using published TG119 report results.


  1. AAPM Medical Physics Monograph No. 29, Intensity-Modulated Radiation Therapy, The State of the Art, Jatinder R. Palta and T. Rockwell Mackie, Editors, Medical Physics Publishing,Madison, WI, USA, 2003.
  2. Yu CX, ?Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy.? Phys Med Biol.1995 Sep; 40(9):1435-1449.
  3. Otto K, ?Volumetricmodulated?arc?therapy:?IMRT?in a?single?gantry?arc.? MedPhys, 2008 Jan; 35(1):310-317.
  4. Low DA et al.,??Dosimetry tools and techniques for IMRT.? Med Phys.?2011 Mar;38(3):1313-1338.[ A Report from AAPM TG-120].
  1. Markus Alber et al., ?Guidelines for the verification of IMRT.? 2008. [ESTRO BOOKLET?9].
  2. R. Palta et al., ?Credentialing of institutions for IMRT in clinical trials,? Int. J. Radiat. Oncol., Biol., Phys. 2004 Jul 15;59(4):1257-9.
  3. S. Ibbott et al., ?Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials,? Int. J. Radiat. Oncol., Biol., Phys. 2008;71(1 Suppl):S71-5.
  4. Molineu A et al.,??Credentialing?results?from?IMRT?irradiations?of an anthropomorphic head and neck phantom.? Med Phys.2013 Feb; 40(2):022101.
  5. Ezzell GA et al., ?IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119.? Med Phys. 2009; 36(11):5359?73.
  6. Narayanasamy G et al.,??Commissioning?an Elekta?Versa?HD?linear accelerator.? J Appl Clin Med Phys.?2016 Jan 8;17(1):5799.
  7. Snyder M et al.,??Modeling?the?Agility?MLC?in the?Monaco?treatment?planning?system.? J Appl Clin Med Phys.?2016 May 8;17(3):6044.
  8. Saenz DL et al.,??Pinnacle3?modeling?and?end-to-end?dosimetric?testing?of a Versa HD linear accelerator with the?Agility head?and?flattening?filter-free?modes.? J Appl Clin Med Phys.?2016 Jan 8;17(1):5808.
  9. Das IJ et al.,??Accelerator beam data commissioning equipment and procedures: report of the?TG-106?of the Therapy Physics Committee of the?AAPM.? Med Phys.?2008 Sep;35(9):4186-215.
  1. Low DA et al., ?A technique for the quantitative evaluation of dose distributions.? Med. Phys. 25: 656-661, 1998.
  2. Mynampati DK et al., ?Application of AAPM TG 119 to volumetric arc therapy (VMAT)? J Appl Clin Med Phys. (2012).
  3. Nithya L et al.,?Analyzing?the?performance?of the?planning?system?by use of?AAPM?TG?119?test?cases.? Radiol Phys Technol.?2016 Jan;9(1):22-9.
  4. Kim JI et al.,??A multi-institutional study for tolerance and action levels of IMRT dose quality assurance measurements in Korea.? J Appl Clin Med Phys.?2013 Mar 4;14(2):3964.
  5. Wen N et al.,??IMRT and RapidArc commissioning of a TrueBeam linear accelerator using TG-119 protocol cases.? J Appl Clin Med Phys.?2014 Sep 8;15(5):4843.
  6. Gordon JD et al., ?Confidence limit variation for a single IMRT system following the TG119 protocol.? Med Phys.?2011 Mar; 38(3):1641-8.
  1. Saminathan S et al., ?Plan evaluation and dosimetric comparision of IMRT using AAPM TG119 test suites ans recommendations.? Australas Phys Eng Sci Med.2011 Apr;34(1):55-61.
  2. Thomas M et al.,?Local confidence limits for IMRT and VAMT technique: a study based on TG119 test suite.? Australas Phys Eng Sci Med.?2014 Mar;37(1):59-74.
  3. Kadam A et al., ?Estimation of local confidence limit for 6 MV photon beam IMRT system using AAPM TG 119 test protocol.? Int J Cancer Ther Oncol. 2016; 4(1):4110.
  4. McVicker D et al.,??On the sensitivity of TG-119 and IROC credentialing to TPS commissioning errors.? J Appl Clin Med Phys.?2016 Jan 8;17(1):5452.
  5. Knill C et al.,??An analysis of confidence limit calculations used in AAPM Task Group No. 119.? Med Phys.?2011 Apr;38(4):1779-84.
  6. Kim JI et al.,??Confidence limits for patient-specific IMRT dose QA: a multi-institutional study in Korea.? J Appl Clin Med Phys.?2016 Jan 8;17(1):5607.

[Seema Sharma MSc Dip, RP Subhash Chander, MD Velliyan Subramani, PhD Pratik Kumar, PhD Suman Bhaskar, MD Sushmita Pathy, MD Sanjay Thulkar, MD N.Gopishankar, PhD Megha Sairem, MSc, Dip. RP Ashish Binjola MSc Dip, RP Dhayanethi N, MSc Pradeep Kumar S., MSc Priyanka Agarwal, MSc Dip. RP. (2017); IMRT AND VMAT COMMISSIONING FOR VERSA HD LINEAR ACCELERATOR USING AAPM TG-119. Int. J. of Adv. Res. 5 (Apr). 352-362] (ISSN 2320-5407). www.journalijar.com


Seema Sharma
Medical Physicist, Department of Radiation Oncology, Dr.B.R.A. Institute Rotary Cancer Hospital (IRCH), All India Institute of Medical Sciences (AIIMS) New Delhi

DOI:


Article DOI: 10.21474/IJAR01/3819      
DOI URL: http://dx.doi.org/10.21474/IJAR01/3819